{"id":450262,"date":"2021-03-03T21:19:50","date_gmt":"2021-03-04T02:19:50","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=450262"},"modified":"2021-03-03T21:19:50","modified_gmt":"2021-03-04T02:19:50","slug":"icad-to-participate-in-the-cowen-41st-annual-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/","title":{"rendered":"iCAD to Participate in the Cowen 41st Annual Health Care Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NASHUA, N.H., March  03, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qXKnB5fXjGotcRMy4CbmEXp1VUdGde10rLH4UnH0WRsW0Pm1pCWURNC0KWlcFvMBqPPvXsvAOMblouyNyy181g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">iCAD, Inc<\/a>. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCAD\u2019s Chairman and Chief Executive Officer, will deliver a formal presentation at the Cowen 41<sup>st<\/sup> Annual Health Care Conference on Thursday, March 4<sup>th<\/sup> at 12:10pm ET and will also conduct one-on-one meetings with investors.<\/p>\n<p>A live audio webcast of the presentation will be available by clicking <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HvrSjXLhsm20_4ngHxNoiu7yv-G93TTwgCLit7r_zoJi1hBfWgFue3ccFcQmGvGUjwRYO4v0RaFsN5_BzUZdjqDdWl4ioGFDwzNvJOTkN5oZhsIsF88U-DGp6R-Gx8PrrFMUD-150m2rF1peD-AHSA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/wsw.com\/webcast\/cowen81\/icad\/1908885<\/a>, as well as on the \u201cEvents &amp; Webcasts\u201d section of iCAD\u2019s investor website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HvrSjXLhsm20_4ngHxNoisbwaxxCxEo384_HbeTzAMogEObQ5UpF9xANk_H3KVoNQQ2SpQyRwFR0E5S2FPSAsc2kfjtoN3hE_FvADZ9Z8coebKGcpv3YusiytuFAVJq81TfZs4u7DQxutA-SQHIz42bpPzEO-fBT5o9eCyd-_BZ9RmoA3cBfKvWuNzHrIzKh\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.icadmed.com\/financial-news-and-events.html<\/a>. A replay of the webcast will be available on the Company\u2019s website.<\/p>\n<p>\n        <strong>About iCAD, Inc.<\/strong>\n      <\/p>\n<p>Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions.<\/p>\n<p>ProFound AI\u2122 is a high-performing workflow solution for 2D and 3D mammography, or digital breast tomosynthesis (DBT), featuring the latest in deep-learning artificial intelligence. In 2018, ProFound AI for Digital Breast Tomosynthesis (DBT) became the first artificial intelligence (AI) software for DBT to be FDA-cleared; it was also CE marked and Health Canada licensed that same year. It offers clinically proven time-savings benefits to radiologists, including a reduction of reading time by 52.7 percent, thereby halving the amount of time it takes radiologists to read 3D mammography datasets. Additionally, ProFound AI for DBT improved radiologist sensitivity by 8 percent and reduced unnecessary patient recall rates by 7.2 percent.<\/p>\n<p>The Xoft System is FDA-cleared, CE marked and licensed in a growing number of countries for the treatment of cancer anywhere in the body. It uses a proprietary miniaturized x-ray source to deliver a precise, concentrated dose of radiation directly to the tumor site, while minimizing risk of damage to healthy tissue in nearby areas of the body.<\/p>\n<p>For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nKUNeRH953gMvSXaJin-3NW0PDVvJUhyTamfG2PhEYyNkJtDVdzqZTvjC07bl-Bx2116HYH9B-GlDorY1DUQ4Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.icadmed.com<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KTC7_0jhNUvegN6hMifrLUd4Q7pox_PKIWA3PZxLwWet7-AWTQPFxN--O_3w20p5yLNPXr_ojwlDCQ4PLs84Wg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.xoftinc.com<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>Certain statements contained in this News Release constitute \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the future prospects for the Company\u2019s technology platforms and products. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited, to the Company\u2019s ability to achieve business and strategic objectives, the ability of IORT to alleviate the burden to our health system and minimize a patient\u2019s potential exposure to Covid-19, to be more beneficial for patients that traditional therapy or to be accepted by patients or clinicians, the impact of supply and manufacturing constraints or difficulties, uncertainty of future sales levels, to defend itself in litigation matters, protection of patents and other proprietary rights, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence of products, increased competition, litigation and\/or government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company\u2019s filings with the Securities and Exchange Commission. The words \u201cbelieve,\u201d \u201cdemonstrate,\u201d \u201cintend,\u201d \u201cexpect,\u201d \u201cestimate,\u201d \u201cwill,\u201d \u201ccontinue,\u201d \u201canticipate,\u201d \u201clikely,\u201d \u201cseek,\u201d and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1axevnFQUrIHPYKW7zZG5tSlyokb5vMVLKZYhB0B40nmuOqU_-3ddR9Gay3vP7dV54b8YMqT8M7tHXPVlwn7zI6JlNgUZhf8BLnvr4EoPoQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.icadmed.com<\/a>\u00a0and on the SEC\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1axevnFQUrIHPYKW7zZG5io6Q5dCJH5Vz3_WmGdJU0PxI1h5TsSDYz7PgwrzqU-GVsXbPxIJmOGbhTeS6WlpIQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.sec.gov<\/a>.<\/p>\n<p align=\"justify\">Contacts:<br \/>Media inquiries:<br \/>Jessica Burns, iCAD \u00a0<br \/>+1-201-423-4492<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TuzJLsjgC9Tyy78nvh6cYX6v1qPPmmTz-doDS_UDqSLEQ6ZuuJFO_eMHLuTorv2-4IOn7M5xuUd1SR77tWpesK2mighaq_qlJ2Tr5ss3nb8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jburns@icadmed.com<\/a><\/p>\n<p align=\"justify\">Investor Relations:<br \/>Jeremy Feffer, LifeSci Advisors<br \/>+1-212-915-2568<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RkzkQQ018c-43OS2k8bFdSsRaGGlT19pu_LF-21HQXW-J_2B2QqUiIzMTRLBLXN4kR--0r31SOJe4faaGwsreYRdBBE0ArHfVEczAtuBYGtKt6AZHJcXYMTwGxEFEldJ\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jeremy@lifesciadvisors.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ddb18407-06f1-48a9-8ddd-087cae9c2309\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NASHUA, N.H., March 03, 2021 (GLOBE NEWSWIRE) &#8212; iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCAD\u2019s Chairman and Chief Executive Officer, will deliver a formal presentation at the Cowen 41st Annual Health Care Conference on Thursday, March 4th at 12:10pm ET and will also conduct one-on-one meetings with investors. A live audio webcast of the presentation will be available by clicking https:\/\/wsw.com\/webcast\/cowen81\/icad\/1908885, as well as on the \u201cEvents &amp; Webcasts\u201d section of iCAD\u2019s investor website, https:\/\/www.icadmed.com\/financial-news-and-events.html. A replay of the webcast will be available on the Company\u2019s website. About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;iCAD to Participate in the Cowen 41st Annual Health Care Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-450262","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>iCAD to Participate in the Cowen 41st Annual Health Care Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iCAD to Participate in the Cowen 41st Annual Health Care Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NASHUA, N.H., March 03, 2021 (GLOBE NEWSWIRE) &#8212; iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCAD\u2019s Chairman and Chief Executive Officer, will deliver a formal presentation at the Cowen 41st Annual Health Care Conference on Thursday, March 4th at 12:10pm ET and will also conduct one-on-one meetings with investors. A live audio webcast of the presentation will be available by clicking https:\/\/wsw.com\/webcast\/cowen81\/icad\/1908885, as well as on the \u201cEvents &amp; Webcasts\u201d section of iCAD\u2019s investor website, https:\/\/www.icadmed.com\/financial-news-and-events.html. A replay of the webcast will be available on the Company\u2019s website. About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection &hellip; Continue reading &quot;iCAD to Participate in the Cowen 41st Annual Health Care Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T02:19:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"iCAD to Participate in the Cowen 41st Annual Health Care Conference\",\"datePublished\":\"2021-03-04T02:19:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/\"},\"wordCount\":687,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/\",\"name\":\"iCAD to Participate in the Cowen 41st Annual Health Care Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=\",\"datePublished\":\"2021-03-04T02:19:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iCAD to Participate in the Cowen 41st Annual Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iCAD to Participate in the Cowen 41st Annual Health Care Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"iCAD to Participate in the Cowen 41st Annual Health Care Conference - Market Newsdesk","og_description":"NASHUA, N.H., March 03, 2021 (GLOBE NEWSWIRE) &#8212; iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, iCAD\u2019s Chairman and Chief Executive Officer, will deliver a formal presentation at the Cowen 41st Annual Health Care Conference on Thursday, March 4th at 12:10pm ET and will also conduct one-on-one meetings with investors. A live audio webcast of the presentation will be available by clicking https:\/\/wsw.com\/webcast\/cowen81\/icad\/1908885, as well as on the \u201cEvents &amp; Webcasts\u201d section of iCAD\u2019s investor website, https:\/\/www.icadmed.com\/financial-news-and-events.html. A replay of the webcast will be available on the Company\u2019s website. About iCAD, Inc. Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection &hellip; Continue reading \"iCAD to Participate in the Cowen 41st Annual Health Care Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T02:19:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"iCAD to Participate in the Cowen 41st Annual Health Care Conference","datePublished":"2021-03-04T02:19:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/"},"wordCount":687,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/","name":"iCAD to Participate in the Cowen 41st Annual Health Care Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=","datePublished":"2021-03-04T02:19:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDIxNSM0MDQ3NTI1IzIwMDg2Mjg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/icad-to-participate-in-the-cowen-41st-annual-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"iCAD to Participate in the Cowen 41st Annual Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=450262"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/450262\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=450262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=450262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=450262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}